Cargando…
Engineering of the current nucleoside-modified mRNA-LNP vaccines against SARS-CoV-2
Currently, there are over 230 different COVID-19 vaccines under development around the world. At least three decades of scientific development in RNA biology, immunology, structural biology, genetic engineering, chemical modification, and nanoparticle technologies allowed the accelerated development...
Autores principales: | Granados-Riveron, Javier T., Aquino-Jarquin, Guillermo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Masson SAS.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8299225/ https://www.ncbi.nlm.nih.gov/pubmed/34343897 http://dx.doi.org/10.1016/j.biopha.2021.111953 |
Ejemplares similares
-
CRISPR/Cas13-Based Approaches for Ultrasensitive and Specific Detection of microRNAs
por: Granados-Riveron, Javier T., et al.
Publicado: (2021) -
Does the linear
Sry transcript function as a ceRNA for miR-138? The sense of antisense
por: Granados-Riveron, Javier Tadeo, et al.
Publicado: (2014) -
An efficient approach for SARS-CoV-2 monoclonal antibody production via modified mRNA-LNP immunization
por: Hsu, Fu-Fei, et al.
Publicado: (2022) -
Impact of Ribosome Activity on SARS-CoV-2 LNP – Based mRNA Vaccines
por: Tsiambas, Evangelos, et al.
Publicado: (2021) -
Development of an LNP-Encapsulated mRNA-RBD Vaccine against SARS-CoV-2 and Its Variants
por: Liu, Cong, et al.
Publicado: (2022)